SCHEMBL4454569

SCHEMBL4454569

CC(C)(CCNC=O)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 2/20 0.44
ADH1B P00325 3/20 0.42
ADH1A P07327 3/20 0.42
ADH7 P40394 3/20 0.42
ADH1C P00326 2/20 0.42
KCNN4 O15554 2/20 0.38
CYP2C19 P33261 1/20 0.36
HIF1A Q16665 1/20 0.36
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC10 Q969S8 1/20 0.35
HDAC11 Q96DB2 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
HDAC9 Q9UKV0 1/20 0.35
HDAC5 Q9UQL6 1/20 0.35
NR3C2 P08235 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5965957 0.81 TAAR1 (0.47) TAAR1ADH1BADH1AADH7ADH1C
SCHEMBL16369385 0.80 TAAR1 (0.50) TAAR1KCNN4ALDH1A1HTTKDM4E
SCHEMBL1834441 0.79 TAAR1 (0.48) TAAR1ADH1BADH1AADH7ADH1C
SCHEMBL28434959 0.75 CYP2C19 (0.44) TAAR1CYP2C19HIF1AHDAC3HDAC4
SCHEMBL3368788 0.75 TAAR1 (0.64) TAAR1KCNN4CYP2C19HIF1AALDH1A1
SCHEMBL24303418 0.75 TAAR1 (0.48) TAAR1KCNN4CYP2C19HIF1AALDH1A1
SCHEMBL29078982 0.74 ADH1B (0.47) ADH1BADH1AADH7ADH1CCYP2C19
SCHEMBL9852888 0.73 ADH1B (0.45) TAAR1ADH1BADH1AADH7ADH1C
SCHEMBL6751138 0.72 KIF11 (0.55) ADH1BADH1AADH7ADH1CKCNN4
SCHEMBL7832303 0.71 CCR1 (0.37) ADH1BADH1AADH7ADH1CHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1542723-A4 CROSS-LINKERS WITH HIGH REACTIVITY AND SOLUBILITY AND THEIR USE IN THE PREPARATION OF CONJUGATES FOR TARGETED DELIVERY OF SMALL MOLECULE DRUGS IMMUNOGEN INC (US) 2009-02-11 EP disclosed
EP-1542723-A2 CROSS-LINKERS WITH HIGH REACTIVITY AND SOLUBILITY AND THEIR USE IN THE PREPARATION OF CONJUGATES FOR TARGETED DELIVERY OF SMALL MOLECULE DRUGS Immunogen, Inc. (US) 2005-06-22 EP disclosed
WO-2004016801-A2 CROSS-LINKERS WITH HIGH REACTIVITY AND SOLUBILITY AND THEIR USE IN THE PREPARATION OF CONJUGATES FOR TARGETED DELIVERY OF SMALL MOLECULE DRUGS IMMUNOGEN, INC. (US) 2004-02-26 WO disclosed